Ochre Bio
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
Y Combinator
yc-company-directory #4195Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
sourceOchre Bio is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Ochre Bio
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Persist AI
match 45It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
shared extracted concept terms: chronic, disease; shared product terms: develop, chronic, disease; shared affiliation: Y Combinator
Serna Bio
match 33Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities.
shared product terms: bio, develop, rna, disease; shared affiliation: Y Combinator
SökerData
match 29SokerData is a biotechnology company that provides research, and data analysis solutions for disease-related datasets.
shared extracted concept terms: disease; shared product terms: biotechnology, disease; same category: Healthcare
Gerostate Alpha
match 28Developing novel therapeutics for aging and chronic disease
shared product terms: develop, chronic, disease; same category: Healthcare; shared affiliation: Y Combinator
Engage Bio
match 25Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.
shared product terms: bio, develop, medicine; shared affiliation: Y Combinator
Nautilus Biotechnology
match 8Healthcare company.
same category: Healthcare; shared terms: biotechnology, healthcare